KAPA

Kairos Pharma, Ltd.

10 hedge funds and large institutions have $173K invested in Kairos Pharma, Ltd. in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
SFG
1
SevenBridge Financial Group
Pennsylvania
$49.6K
XT
2
XTX Topco
Cayman Islands
$44.5K +$44.5K +62,746 New
ACA
3
Aptus Capital Advisors
Alabama
$31.4K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$15.5K +$972 +1,371 +7%
TSS
5
Two Sigma Securities
New York
$9.61K +$9.61K +13,555 New
HF
6
HRT Financial
New York
$9K +$9K +13,239 New
UBS Group
7
UBS Group
Switzerland
$6.71K +$4.73K +6,666 +239%
Citigroup
8
Citigroup
New York
$3.9K +$3.9K +5,499 New
TRCT
9
Tower Research Capital (TRC)
New York
$2.69K +$2.69K +3,797 New
Bank of America
10
Bank of America
North Carolina
$36 +$21 +30 +143%
AC
11
Armistice Capital
New York
-$1.31M -1,404,000 Closed
SRL
12
Scientech Research LLC
New Jersey
-$45.1K -48,198 Closed
Citadel Advisors
13
Citadel Advisors
Florida
-$12.4K -13,230 Closed